个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Li Ting[1] ; Liu Xiaojie[1] ; Long Xiaoyi[1] ; Li Yangyou[2] ; Xiang Jin[3] ; Lv Yuanxia[4] ; Zhao Xiaoyang[1] ; Shi Shaoqing[5,*1] ; Chen Wei[1,*2] ;
机构： [1]Institute of Basic Medical and Forensic Medicine, North Sichuan Medical College, Nanchong, China. [2]Animal Experimental Center, North Sichuan Medical College, Nanchong, China. [3]School of Clinical Medicine, North Sichuan Medical College, Nanchong, China. [4]School of Pharmacy, North Sichuan Medical College, Nanchong, China. [5]Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming, China.
出处：
DOI： 10.1002/tox.23871
ISSN：

关键词： AMPK brexpiprazole colorectal cancer lipogenesis SREBP1

摘要：
In the present study, we investigated the role of brexpiprazole on cell proliferation and lipogenesis in colorectal cancer (CRC) and its molecular mechanism.The effect of brexpiprazole on CRC cell proliferation was determined by CCK-8, EdU assay, cell clone formation. The flow cytometry was evaluated cell cycle. Differential expression genes (DEGs) were identified by RNA-seq assay after treating HCT116 cells with or without 20 μM brexpiprazole for 24 h. Then, the top 120 DEGs were analyzed by GO and KEGG enrichment analysis. After that, Oil red O staining and the levels of total cholestenone and triglyceride were measured to assess lipogenesis capacity in CRC cells. The related molecules of cell proliferation, lipogenic and AMPK/SREBP1 signal pathways were measured by q-PCR, western blot and immunohistochemical staining.Brexpiprazole remarkably suppressed cell proliferation, lipogenesis, and induced cell cycle arrest in CRC. The underlying mechanisms probably involved the suppression of SREBP1 and the stimulation of AMPK.Brexpiprazole inhibited cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in CRC.© 2023 Wiley Periodicals LLC.

基金：
Provincial key cultivation project of Science and Technology Development Plan of North Sichuan Medical College, Grant/Award Number: CYB22-ZDA11; Talent Project of First Affiliated Hospital of Kunming Medical University, Grant/Award Number: 2022535Q02; Strategic Cooperation Research Project of Nanchong, Grant/Award Number: 22SXQT0332
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 3 区 医学
小类 | 2 区 环境科学 2 区 毒理学 2 区 水资源
最新[2023]版：
大类 | 3 区 医学
小类 | 2 区 环境科学 2 区 毒理学 2 区 水资源
JCR分区：
出版当年[2023]版：
Q1 TOXICOLOGY Q1 WATER RESOURCES Q2 ENVIRONMENTAL SCIENCES
最新[2023]版：
Q1 TOXICOLOGY Q1 WATER RESOURCES Q2 ENVIRONMENTAL SCIENCES

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者：
第一作者机构： [1]Institute of Basic Medical and Forensic Medicine, North Sichuan Medical College, Nanchong, China.
通讯作者：
通讯机构： [1]Institute of Basic Medical and Forensic Medicine, North Sichuan Medical College, Nanchong, China. [5]Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming, China. [*1]Scientific Research Laboratory Center, First Affiliated Hospital of Kunming Medical University, Kunming 650032, China. [*2]Institute of Basic Medical and Forensic Medicine, North Sichuan Medical College, Nanchong 637100, China.
推荐引用方式(GB/T 7714)：
Li Ting,Liu Xiaojie,Long Xiaoyi,et al.Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer[J].ENVIRONMENTAL TOXICOLOGY.2023,38(10):2352-2360.doi:10.1002/tox.23871.
APA：
Li Ting,Liu Xiaojie,Long Xiaoyi,Li Yangyou,Xiang Jin...&Chen Wei.(2023).Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer.ENVIRONMENTAL TOXICOLOGY,38,(10)
MLA：
Li Ting,et al."Brexpiprazole suppresses cell proliferation and de novo lipogenesis through AMPK/SREBP1 pathway in colorectal cancer".ENVIRONMENTAL TOXICOLOGY 38..10(2023):2352-2360

相关文献

[1]Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway. [2]Hepatic glycogenesis antagonizes lipogenesis by blocking S1P via UDPG [3]Apelin-mediated deamidation of HMGA1 promotes tumorigenesis by enhancing SREBP1 activity and lipid synthesis [4]AMPK参与肿瘤能量代谢研究进展 [5]Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans. [6]Dysregulated m6A Modification Promotes Lipogenesis and Development of Non-alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. [7]SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways. [8]PRKAA/AMPK restricts HBV replication through promotion of autophagic degradation. [9]Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells. [10]Glycolysis and de novo fatty acid synthesis cooperatively regulate pathological vascular smooth muscle cell phenotypic switching and neointimal hyperplasia

资源点击量：43389 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号